Literature DB >> 3233859

Nimodipine treatment of subarachnoid hemorrhage.

J Laursen1, F Jensen, E Mikkelsen, P Jakobsen.   

Abstract

In a pilot study of 6 patients with subarachnoid hemorrhage caused by a ruptured intracranial (grade IV (Hunt and Hess) aneurysm the hemodynamics and plasma-nimodipine concentrations have been observed during a 3-week period of treatment. We found that 3 patients developed reversible hypotension during the nimodipine treatment and that the hypotension tendency could be related to the plasma-nimodipine level and not to a more or less severe sensitivity to nimodipine. Repeated measurements of blood pressure, plasma-nimodipine and regional cerebral blood flow (rCBF) are necessary for the purpose of obtaining the optimum treatment and for evaluating the effect of treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3233859     DOI: 10.1016/0303-8467(88)90005-4

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Investigation of nimodipine pharmacokinetics in Chinese patients with acute subarachnoid haemorrhage.

Authors:  C R Kumana; M Kou; Y L Yu; K Y Fong; C F Fung; C M Chang; W Mück; I J Lauder
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 2.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

3.  Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex.

Authors:  Janne Koskimäki; Nobuaki Matsui; Juzoh Umemori; Tomi Rantamäki; Eero Castrén
Journal:  Cell Mol Neurobiol       Date:  2014-09-10       Impact factor: 5.046

4.  Intracranial biodegradable silica-based nimodipine drug release implant for treating vasospasm in subarachnoid hemorrhage in an experimental healthy pig and dog model.

Authors:  Janne Koskimäki; Miikka Tarkia; Tuula Ahtola-Sätilä; Lasse Saloranta; Outi Simola; Ari-Pekka Forsback; Aki Laakso; Janek Frantzén
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.